Bicocca Open Archive

Logo unimib boa
PIPERNO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.253
AS - Asia 10.208
EU - Europa 8.355
SA - Sud America 1.474
AF - Africa 229
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 42.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.844
SG - Singapore 3.723
CN - Cina 2.343
HK - Hong Kong 1.525
RU - Federazione Russa 1.316
CA - Canada 1.289
IT - Italia 1.167
DE - Germania 1.094
SE - Svezia 1.086
BR - Brasile 1.074
VN - Vietnam 1.056
IE - Irlanda 968
UA - Ucraina 860
GB - Regno Unito 478
FR - Francia 423
IN - India 311
FI - Finlandia 276
BD - Bangladesh 266
AT - Austria 156
AR - Argentina 142
KR - Corea 139
TR - Turchia 127
IQ - Iraq 104
NL - Olanda 95
PK - Pakistan 89
ID - Indonesia 83
JP - Giappone 79
ES - Italia 72
BE - Belgio 65
ZA - Sudafrica 65
MX - Messico 64
DK - Danimarca 61
PL - Polonia 61
SA - Arabia Saudita 61
EC - Ecuador 53
CO - Colombia 49
PH - Filippine 48
UZ - Uzbekistan 48
VE - Venezuela 46
PE - Perù 36
BG - Bulgaria 31
MA - Marocco 28
ET - Etiopia 27
CL - Cile 26
KE - Kenya 25
LT - Lituania 25
MY - Malesia 23
PY - Paraguay 22
EG - Egitto 20
CH - Svizzera 19
NP - Nepal 19
TN - Tunisia 19
JO - Giordania 17
AE - Emirati Arabi Uniti 15
AU - Australia 15
IR - Iran 15
RO - Romania 15
DO - Repubblica Dominicana 14
BO - Bolivia 13
OM - Oman 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
KZ - Kazakistan 12
DZ - Algeria 11
CR - Costa Rica 10
TW - Taiwan 10
IL - Israele 9
TH - Thailandia 9
UY - Uruguay 9
AZ - Azerbaigian 8
GR - Grecia 8
PS - Palestinian Territory 8
BH - Bahrain 7
HR - Croazia 7
KG - Kirghizistan 7
PA - Panama 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
EU - Europa 6
JM - Giamaica 6
PT - Portogallo 6
BA - Bosnia-Erzegovina 5
NG - Nigeria 5
NO - Norvegia 5
GE - Georgia 4
LB - Libano 4
MD - Moldavia 4
SV - El Salvador 4
AL - Albania 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LV - Lettonia 3
MT - Malta 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SC - Seychelles 3
AO - Angola 2
Totale 42.490
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.013
Singapore 2.162
Ashburn 1.802
Woodbridge 1.748
Hong Kong 1.490
Fairfield 1.438
Houston 1.347
San Jose 1.028
Chandler 1.026
Toronto 998
Dublin 934
Jacksonville 909
Wilmington 751
Frankfurt am Main 674
Seattle 581
Dearborn 565
Cambridge 514
New York 449
Princeton 361
Santa Clara 355
Beijing 341
Chicago 298
Los Angeles 298
The Dalles 294
Ho Chi Minh City 288
Milan 280
Hanoi 248
Nanjing 236
Dallas 209
Shanghai 189
Hefei 185
Lauterbourg 175
Lawrence 174
Lachine 155
Altamura 134
Vienna 129
Seoul 128
Council Bluffs 124
Buffalo 120
Moscow 113
São Paulo 110
Boardman 105
San Diego 94
Nanchang 75
Munich 73
Helsinki 72
Andover 67
Guangzhou 66
Shenyang 65
Orem 63
Brussels 54
Hebei 54
London 54
Jinan 49
Changsha 47
Dong Ket 47
Tokyo 47
Rome 46
Jakarta 44
Ottawa 44
Montreal 43
Tianjin 43
Rio de Janeiro 42
Da Nang 41
Tashkent 41
Jiaxing 40
Turku 40
Warsaw 38
Belo Horizonte 37
Falls Church 36
Chennai 35
Dhaka 35
Brooklyn 34
Nuremberg 34
Salt Lake City 34
Zhengzhou 34
Phoenix 33
Baghdad 31
Denver 30
Haiphong 30
Johannesburg 28
Lahore 27
Philadelphia 27
Columbus 26
Addis Ababa 24
Atlanta 24
Mountain View 24
Norwalk 24
Boston 23
Fremont 23
Ningbo 23
Mumbai 22
Tampa 22
Hải Dương 21
Paris 21
Plovdiv 21
Quito 21
Stockholm 21
Amsterdam 20
Brasília 20
Totale 28.732
Salva come PNG Salva come JPEG
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 680
Hepcidin regulation in a mouse model of acute hypoxia 589
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 439
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 409
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 407
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 385
Hif1a: A putative modifier of hemochromatosis 381
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 380
Idiopathic erythrocytosis: a germline disease? 374
Juvenile Hemochromatosis 347
Inherited iron overload disorders 344
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 340
Type 3 hemochromatosis and beta-thalassemia trait 339
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 333
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 333
Hepcidin regulation in a mouse model of acute hypoxia 331
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 330
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 329
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 328
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 321
Unexplained isolated hyperferritinemia without iron overload 318
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 316
Circulating factors are involved in hypoxia-induced hepcidin suppression 313
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 304
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 301
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 298
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 298
Early impairment of large artery structure and function in Type I diabetes mellitus 297
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 295
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 294
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 290
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 289
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 288
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 287
Hepatocellular carcinoma in Gaucher disease: an international case series 285
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 283
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 281
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 280
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 279
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 278
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 278
Ferroportin disease: A novel SLC40A1 mutation 278
Hyperferritinemia and diagnosis of type 1 Gaucher disease 277
Increased serum ferritin is common in men with essential hypertension 274
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 274
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 274
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 273
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 269
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 269
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 267
Ceruloplasmin variants might have different effects in different iron overload disorders 266
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 265
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 264
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 259
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: The causes might be more heterogeneous than in thalassaemia 254
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 253
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 253
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 252
Different cortical excitability profiles in hereditary brain iron and copper accumulation 252
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 251
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 250
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 250
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 250
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 250
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 247
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 246
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 246
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 244
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 244
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 244
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 243
Commentary 243
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 242
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 240
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 237
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 236
Homozygous deletion of HFE: The Sardinian hemochromatosis? 236
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 234
Haemochromatosis in patients with β-thalassaemia trait 234
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 234
Biochemical and genetic defects underlying human congenital hypotransferrinemia 233
The iron status of Italian subjects with beta-thalassemia trait 230
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 228
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 227
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 227
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 225
Natural history of juvenile haemochromatosis 223
Myelodysplastic Syndromes and Iron Chelation Therapy 223
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 220
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 220
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 220
Erythrocyte ferritin in thalassemia syndromes 219
Erythrocyte ferritin in patients on chronic hemodialysis treatment 218
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 215
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 214
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 213
Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload 213
Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course 211
Blunted hepcidin response to oral iron challenge in HFE-hemochromatosis 208
Long-Term Survival and Risk of Hepatocellular Carcinoma Occurrence in Italian Patients with Hereditary Hemochromatosis 207
Totale 28.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 0 0 235
2021/20222.444 110 261 325 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/202614.174 1.331 757 1.018 1.460 1.782 795 2.094 665 1.207 1.265 1.425 375
Totale 43.319